MRNA
shares have maintained a positive posture in terms of Ichimoku Cloud trend bearing, with plenty of room to go on the upside according to recent RSI peaks. That said, this is a Biotech, which means technicals only indicate a small piece of the story, dwarfed by potential headlines still to come.